BUPROPION HYDROCHLORIDE | N021515 | BAUSCH HEALTH US LLC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 150MG
RLDAB3
0 patents0 exclusivities▴
TABLET, EXTENDED RELEASE;ORAL | Approved: Aug 28, 2003
No patent or exclusivity listings for this strength.
#002 — 300MG
RLDAB3
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Aug 28, 2003